Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
0.990
-0.060 (-5.70%)
At close: Nov 21, 2024, 4:00 PM
1.000
+0.010 (0.99%)
After-hours: Nov 21, 2024, 4:05 PM EST
CNTB Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -21.38 | -59.5 | -118.09 | -202.27 | -779.23 | -168.63 | |
| Depreciation & Amortization | 0.96 | 0.99 | 1.03 | 0.63 | 1.44 | 0.79 | |
| Loss (Gain) From Sale of Assets | - | 0.1 | - | 0.04 | - | - | |
| Asset Writedown & Restructuring Costs | - | - | 4.7 | - | - | - | |
| Stock-Based Compensation | 2.8 | 3.26 | 6.91 | 8.99 | 25.19 | 3.88 | |
| Other Operating Activities | -0.63 | -2.26 | -2.52 | 104.7 | 588.28 | 57.28 | |
| Change in Accounts Receivable | 1.71 | 1.04 | 4.05 | -2.31 | -9.35 | -3.03 | |
| Change in Accounts Payable | -5.82 | -4.28 | -0.78 | 8.97 | 1.85 | 19.35 | |
| Change in Unearned Revenue | -3.33 | 13.07 | - | - | - | - | |
| Change in Other Net Operating Assets | 0.95 | -0.36 | 3.19 | -3.08 | 4.65 | 0.1 | |
| Operating Cash Flow | -24.75 | -47.93 | -101.52 | -84.32 | -167.16 | -90.26 | |
| Capital Expenditures | -0.44 | -0.29 | -4.41 | -3.83 | -14.96 | -1.07 | |
| Sale of Property, Plant & Equipment | 2.94 | 2.94 | - | - | - | - | |
| Sale (Purchase) of Intangibles | - | - | - | -0.05 | -0.35 | - | |
| Investment in Securities | 50.94 | 72.59 | -81.84 | 2.12 | 18.24 | -2.27 | |
| Other Investing Activities | -0.09 | -0.08 | - | -3.44 | - | - | |
| Investing Cash Flow | 53.34 | 75.16 | -86.24 | -5.21 | 2.93 | -3.34 | |
| Long-Term Debt Repaid | - | -0.29 | -0.22 | -0.13 | -0.54 | -0.45 | |
| Net Debt Issued (Repaid) | -0.29 | -0.29 | -0.22 | -0.13 | -0.54 | -0.45 | |
| Issuance of Common Stock | 0.12 | 0.04 | 0.14 | 220.02 | - | 0.05 | |
| Repurchase of Common Stock | - | - | - | -0.57 | - | - | |
| Other Financing Activities | - | - | - | -17.11 | -3.95 | - | |
| Financing Cash Flow | -0.17 | -0.25 | -0.09 | 202.22 | 918.76 | -0.4 | |
| Foreign Exchange Rate Adjustments | 0.14 | 0.02 | -0.86 | 0.22 | -53.43 | 1.37 | |
| Net Cash Flow | 28.57 | 27 | -188.71 | 112.91 | 701.1 | -92.63 | |
| Free Cash Flow | -25.19 | -48.22 | -105.93 | -88.16 | -182.12 | -91.33 | |
| Free Cash Flow Per Share | -0.46 | -0.88 | -1.92 | -1.69 | -10.66 | -5.41 | |
| Levered Free Cash Flow | -17.08 | -27.07 | -67.55 | -46.03 | -110.87 | -50.83 | |
| Unlevered Free Cash Flow | -17.07 | -27.06 | -67.54 | -46.02 | -109.06 | -50.8 | |
| Change in Net Working Capital | 4.36 | -9.59 | -1.65 | -9.27 | 0.6 | -16.42 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.